IP Library Granted Patent US 11,116,739
Granted Patent B2
US 11,116,739 · App. 15/558,519 · Granted Sep 14, 2021

Fixed dose combinations and formulations comprising ETC1002 and one or more statins and methods of treating or reducing cardiovascular disease

Inventors: Roger Schofield Newton (Ann Arbor, MI); Noah Laban Rosenberg (Livingston, NJ); Diane Elaine MacDougall (Lincoln, MA)
A61K31/20A61K31/22A61K31/366A61K31/40A61K31/405A61K31/47A61K31/505
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,116,739
App. No.
15/558,519
Granted
Sep 14, 2021
Kind
B2
Abstract

Disclosed herein are compositions comprising fixed doses of ETC-1002 and one or more statins. Also disclosed herein are methods for using fixed doses of ETC-1002 and one or more statins. Uses include methods of treating cardiovascular disease or reducing the risk of cardiovascular disease in a subject. Uses also include methods of treating hypercholesterolemia in a subject.

Claims (5)

1. A fixed-dose composition comprising ETC-1002 and one or more statins selected from the group consisting of rosuvastatin and atorvastatin, wherein

the fixed dose of ETC-1002 is 180 mg,

the fixed dose of rosuvastatin is 20-40 mg,

the fixed dose of atorvastatin is 40-80 mg, and

administration of the fixed-dose composition results in an equal or decreased frequency of myalgia compared to the administration of the fixed dose of the one or more statins.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Jul 14, 2026
From: GLAS AMERICAS LLC
To: ESPERION THERAPEUTICS INC.
Reel/Frame 075267/0816 →
PATENT SECURITY AGREEMENT Recorded Jul 13, 2026
From: ESPERION THERAPEUTICS, INC.; RESQ PHARMACEUTICALS LLC
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 075952/0812 →
SECURITY INTEREST Recorded Dec 13, 2024
From: ESPERION THERAPEUTICS, INC.
To: GLAS AMERICAS LLC
Reel/Frame 069582/0756 →
RELEASE OF SECURITY INTEREST Recorded Jun 27, 2024
From: EIGER III SA LLC
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 067963/0094 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 17, 2021
From: NEWTON, ROGER SCHOFIELD; ROSENBERG, NOAH LABAN; MACDOUGALL, DIANE ELAINE
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 057515/0836 →
SECURITY INTEREST Recorded Jun 28, 2019
From: ESPERION THERAPEUTICS, INC.
To: EIGER III SA LLC, AS PURCHASER AGENT
Reel/Frame 049623/0629 →
Continuity (3)
Provisional Application 62133739 · Mar 16, 2015
Provisional Application 62277403 · Jan 11, 2016
Related Publication 20180078518A1 · Mar 22, 2018